Ranking Alexa Global: # 2,478,311
Server:nginx/1.0.15...
The main IP address: 108.171.164.62,Your server United States,San Antonio ISP:Vivus Inc TLD:com CountryCode:US
The description :vivus is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases....
This report updates in 11-Aug-2018
Created Date: | 1994-09-07 |
Changed Date: | 2015-07-01 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host vivus.com. Currently, hosted in United States and its service provider is Vivus Inc .
Latitude: | 29.499677658081 |
Longitude: | -98.39924621582 |
Country: | United States (US) |
City: | San Antonio |
Region: | Texas |
ISP: | Vivus Inc |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx/1.0.15 containing the details of what the browser wants and will accept back from the web server.
Content-Encoding: | gzip |
Transfer-Encoding: | chunked |
Vary: | Accept-Encoding |
Server: | nginx/1.0.15 |
Connection: | keep-alive |
Date: | Sat, 11 Aug 2018 06:12:54 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | NS95.WORLDNIC.com. namehost.WORLDNIC.com. 118061217 10800 3600 604800 3600 |
txt: | "MS=ms95706024" "v=spf1 mx include:spf.protection.outlook.com ip4:12.155.173.2 include:_spf.salesforce.com include:spf.us.emailservice.io include:mail.zendesk.com -all" "z/QXo0x7eIi4HBtKg45K4qQ8MwHyFj8tj+A7z+7XIR81YgjO3JYFJ7ljLGlLjNwXU4dIyzz/Vv4WmINP4JpeTw==" |
ns: | ns96.worldnic.com. ns95.worldnic.com. |
ipv4: | IP:108.171.164.62 ASN:19994 OWNER:RACKSPACE - Rackspace Hosting, US Country:US |
mx: | MX preference = 20, mail exchanger = vivus.com.us.emailservice.cc. MX preference = 30, mail exchanger = vivus.com.us.emailservice.co. MX preference = 10, mail exchanger = vivus.com.us.emailservice.io. |
-- skip to content menu about vivus about vivus inc. the obesity epidemic pulmonary arterial hypertension erectile dysfunction oag compliance careers at vivus our products our products qsymia rems program pipeline + clinical trials investors + media investors + media home stock information financial information news + events investor resources governance contact vivus contact directory careers at vivus advancing innovative clinical therapies with demonstrated clinical development and commercialization expertise, vivus is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. we are a focused organization with the expertise and insights to advance innovative new therapies. news & events access our recent and archived press releases. this section also provides a calendar of upcoming events and presentations. our newsroom investors our investor relations portal provides access to our financial information, filings, investor presentations and stock information. investor tools our products we develop high-potential molecules that have compelling safety and promising efficacy data and transform them into proprietary products that enable significant advances in patient care and outcomes. our products pipeline and therapy development vivus is dedicated to meeting the needs and improving quality of life of patients with serious medical conditions and life-limiting diseases. pulmonary arterial hypertension (pah) pah is a degenerative and life-threatening disease that makes it difficult for the heart to pump blood to the lungs to be oxygenated and may ultimately lead to heart failure. current pah treatment options only address the symptoms, slowing but not preventing disease progression. new therapies that address the underlying cause of disease are urgently needed. learn more latest press releases view all press releases aug 7, 2018 vivus reports second quarter 2018 financial results aug 6, 2018 vivus appoints kenneth suh as president jul 31, 2018 vivus to host second quarter business update and financial results conference call on tuesday, august 7, 2018 jul 10, 2018 vivus announces positive results from a phase 1 clinical trial of vi-0106 patient perspectives understand more about patient needs in the area of pulmonary arterial hypertension (pah) treatment. visit our newsroom pipeline and therapy development striving to bring new therapies to pah patients who have limited treatment options pulmonary arterial hypertension is a degenerative disease with current treatment options that only address the symptoms to slow the progression of the disease. vivus is working to unlock the potential of tacrolimus and ascomycin to significantly improve the quality of life and life expectancy of pah patients. learn more -- other links & resources investors + media relations portal our products our pipeline rems program for qsymia® © 2017 vivus inc. all rights reserved -- terms of use privacy policy sitemap contact © 2017-2018 vivus inc. all rights reserved you are about to leave the vivus inc. website links to third-party websites on vivus.com are provided solely for your convenience. vivus inc. does not control the content contained on any third-party website linked from this website. activities on third-party websites will be governed by the policies and terms of use of those third parties. cancel continue
http://www.vivus.com/about-vivus/about-vivus-inc/
http://www.vivus.com/about-vivus/erectile-dysfunction/
http://www.vivus.com/pipeline/
http://www.vivus.com/about-vivus/oag-compliance/
http://www.vivus.com/our-products/products/
http://www.vivus.com/about-vivus/pulmonary-arterial-hypertension/
http://www.vivus.com/about-vivus/the-obesity-epidemic/
http://www.vivus.com/contact/vivus-contact-directory/
http://www.vivus.com/#skip-to-content
http://www.vivus.com/global/sitemap/
http://www.vivus.com/global/privacy-policy/
http://www.vivus.com/global/terms-of-use/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: VIVUS.COM
Registry Domain ID: 363800_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2015-07-01T17:00:01Z
Creation Date: 1994-09-07T04:00:00Z
Registry Expiry Date: 2020-09-06T04:00:00Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS95.WORLDNIC.COM
Name Server: NS96.WORLDNIC.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-23T22:12:17Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Network Solutions, LLC.
SERVERS
SERVER com.whois-servers.net
ARGS domain =vivus.com
PORT 43
TYPE domain
DOMAIN
NAME vivus.com
CHANGED 2015-07-01
CREATED 1994-09-07
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
NS95.WORLDNIC.COM 207.204.40.148
NS96.WORLDNIC.COM 207.204.21.148
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .